Joint (NASDAQ:JYNT - Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.03) per share for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.
Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings data on Thursday, March 7th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.04. Joint had a negative net margin of 8.19% and a positive return on equity of 7.80%. The firm had revenue of $30.61 million for the quarter, compared to the consensus estimate of $29.63 million. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Joint Stock Down 1.6 %
Shares of NASDAQ:JYNT traded down $0.20 during trading on Thursday, reaching $12.08. 40,270 shares of the company traded hands, compared to its average volume of 89,722. The firm has a fifty day simple moving average of $11.68 and a 200 day simple moving average of $9.92. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.08. Joint has a 1-year low of $7.31 and a 1-year high of $16.48. The firm has a market cap of $180.48 million, a P/E ratio of -18.42 and a beta of 1.59.
Wall Street Analysts Forecast Growth
Separately, TheStreet lowered Joint from a "c-" rating to a "d" rating in a research report on Thursday, March 7th. Three equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $21.50.
Get Our Latest Stock Report on JYNT
Joint Company Profile
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Articles
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
